Tango Therapeutics
Tango Therapeutics is seeking a Senior Director, Clinical Sciences to lead and mentor a team of clinical scientists while providing hands‑on scientific leadership for oncology clinical development programs. The role involves overseeing study design, execution, data analysis, and cross‑functional collaboration to advance precision medicine initiatives.
Headquarters
Boston, Massachusetts, United States
Company Size
51-200 employees
Founded
2017
Tango Therapeutics is a precision oncology company that discovers and develops targeted cancer therapies by exploiting tumor-selective genetic vulnerabilities, especially via synthetic lethality approaches. The company combines functional genomics, computational biology, and a proprietary target-discovery platform to identify novel cancer targets and advance programs from discovery into the clinic. Tango focuses on genetically defined patient populations and partners with pharma to translate its discoveries into therapeutic candidates with the goal of delivering more effective, less toxic treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Tango Therapeutics.
Tango Therapeutics didn’t post a salary, so this is our estimate from similar listings.
Tango Therapeutics’ (TNGX) Sees Cautious Analyst Optimism Following Earnings
3 days ago
Senior Director, Clinical Science
CytomX Therapeutics
Principal Scientist (Clinical Director)
Merck & Co., Inc.
Head of Translational Medicine
Moderna
Global Head of Molecular and Cellular Sciences
Novartis
Head, Section of Thoracic Medical Oncology
oraclecloudinfrastructure
Medical Director, Oncology
CareDx, Inc.